<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02920177</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00104340</org_study_id>
    <nct_id>NCT02920177</nct_id>
  </id_info>
  <brief_title>Platelet-rich Plasma Versus Corticosteroid Injection for the Treatment of Femoroacetabular Impingement</brief_title>
  <official_title>Platelet-rich Plasma Versus Corticosteroid Injection for the Treatment of Femoroacetabular Impingement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the clinical response of intra-articular platelet
      rich plasma (PRP) versus corticosteroid injection in patients affected by femoroacetabular
      impingement (FAI).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will determine if PRP treatment of FAI improves (i) patient reported outcome
      scores and (ii) hip functional stability compared to standard corticosteroid treatment and if
      PRP treatment of FAI reduces (i) radiographic and (ii) biochemical markers of joint
      inflammation and cartilage degradation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in pain score on the visual analog scale at 6 months</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hip Disability and Osteoarthritis Outcome Score (HOOS), Western Ontario and McMaster Universities Arthritis Index (WOMAC), calculated as a sub-score of the HOOS</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Outcome Measurement Information System (PROMIS) Global Health Scale</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Biomarker analysis: IFN-g, IL-6, MCP-1, MIP-1b, IL-1b, TNF-alpha, highly sensitive CRP, COMP.</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Femoroacetabular Impingement</condition>
  <arm_group>
    <arm_group_label>platelet-rich plasma</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>platelet-rich plasma injection into the head-neck junction of the hip joint</description>
  </arm_group>
  <arm_group>
    <arm_group_label>corticosteroid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>corticosteroid injection into the head-neck junction of the hip joint</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>platelet-rich plasma injection</intervention_name>
    <description>platelet-rich plasma injection</description>
    <arm_group_label>platelet-rich plasma</arm_group_label>
    <other_name>PRP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>corticosteroid injection</intervention_name>
    <description>corticosteroid injection</description>
    <arm_group_label>corticosteroid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with symptomatic FAI

          -  Clinical and radiographic evidence of FAI

          -  Patients able to provide consent to study participation

          -  Completion of 6 weeks of physical therapy program

        Exclusion Criteria:

          -  Established Osteoarthritis (Kellgren-Lawrence &gt; 3)

          -  Minimum joint space &gt; 2 mm as measured on AP radiograph

          -  Hip dysplasia (center edge angle &lt; 20Â° on AP radiograph)

          -  Patients with clinically significant cardiovascular, renal, hepatic, endocrine
             disease, cancer or diabetes

          -  Patients with ongoing infection including HIV and Hepatitis

          -  Patient with history of osteomyelitis/septic arthritis

          -  Anticoagulation therapy

          -  Patients who are pregnant or breast feeding

          -  Patients with systemic, rheumatic or inflammatory disease of the knee or
             chondrocalcinosis, hemochromatosis, inflammatory arthritis, arthropathy of the knee
             associated with juxta-articular Paget's disease of the femur or tibia, hemophilic
             arthropathy, infectious arthritis, Charcot's knee joint, villonodular synovitis, and
             synovial chondromatosis

          -  Patients taking immunosuppressant medication

          -  Patients with abnormal hematology or serum chemistry lab results

          -  Patients receiving injection to treatment knee within 2 months of study enrollment

          -  BMI greater than 35 or less than 20
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tariq M Awan, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tariq M Awan, D.O.</last_name>
    <email>awant@umich.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jaimee Gauthier, BA</last_name>
    <phone>734-647-0050</phone>
    <email>jaimeeg@umich.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Michigan Hospital</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaimee Gauthier, BA</last_name>
      <phone>734-647-0050</phone>
      <email>jaimeeg@med.umich.edu</email>
    </contact>
    <contact_backup>
      <last_name>Liz Enselman</last_name>
      <phone>734-615-0768</phone>
      <email>esibilsk@umich.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2016</study_first_submitted>
  <study_first_submitted_qc>September 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2016</study_first_posted>
  <last_update_submitted>August 31, 2017</last_update_submitted>
  <last_update_submitted_qc>August 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Tariq Awan</investigator_full_name>
    <investigator_title>Assistant Professor in Orthopaedic Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Femoracetabular Impingement</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

